96609-16-4
96609-16-4
Chemical Structure
Lifibrol
- CAS No.: 96609-16-4
- Formula:C21H26O4
- Molecular Weight:342.43
IUPAC Name: 4-(4-(4-(tert-butyl)phenyl)-2-hydroxybutoxy)benzoic acid
InChIKey: LNXBEIZREVRNTF-UHFFFAOYSA-N
SMILES: O=C(C1=CC=C(C=C1)OCC(CCC2=CC=C(C=C2)C(C)(C)C)O)O
Biological Activity: Lifibrol is a potent and oral activity hypolipidemic agent. Lifibrol decreases the plasma total cholesterol. Lifibrol has the potential for the research of hypercholesterolemia[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Lifibrol | Lifibrol is a potent and oral activity hypolipidemic agent. Lifibrol decreases the plasma total cholesterol. Lifibrol has the potential for the research of hypercholesterolemia. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Locker PK, et al. Lifibrol: a novel lipid-lowering drug for the therapy of hypercholesterolemia. Lifibrol Study Group. Clin Pharmacol Ther. 1995 Jan;57(1):73-88. [Content Brief]
- [2]. Bell FP, et al. Action of the new hypolipidemic agent lifibrol (K12.148) on lipid homeostasis in normal rats: plasma lipids, hepatic sterologenesis, and the fate of injected [14C]acetate. Lipids. 1993 Dec;28(12):1079-85. [Content Brief]
Keywords
